HeparDx is an emerging NASH/MASH and liver fibrosis blood test designed to diagnose patients earlier and monitor disease progression The data presentations add.
XOMA Announces Exercise of Green Shoe Option and Closes Preferred Stock Offering
December 21, 2020 17:00 ET | Source: XOMA Corporation XOMA Corporation Emeryville, California, UNITED STATES
EMERYVILLE, Calif., Dec. 21, 2020 (GLOBE NEWSWIRE) XOMA Corporation (Nasdaq: XOMA) (“XOMA” or the “Company”) today announced the closing of its previously announced underwritten registered public offering of 984,000 shares, which includes the underwriters option to purchase additional 104,000 shares of its 8.625% Series A Cumulative Perpetual Preferred Stock, with liquidation preference of $25.00 per share (the “Preferred Stock”), at an initial public offering price of $25.00 per share. The offering resulted in net proceeds of approximately $23.4 million after deducting underwriting discounts and commissions, but before deducting expenses and the structuring fee. The Company expects to use the net proceeds of this offering to fu
XOMA Announces Exercise of Green Shoe Option and Closes Preferred Stock Offering – IT Business Net itbusinessnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from itbusinessnet.com Daily Mail and Mail on Sunday newspapers.
EMERYVILLE, Calif., Dec. 10, 2020 (GLOBE NEWSWIRE) XOMA Corporation (NASDAQ:XOMA) ("XOMA" or the "Company") today announced the pricing of its underwritten registered public offering of 880,000 shares of 8.625%
EMERYVILLE, Calif., Dec. 10, 2020 (GLOBE NEWSWIRE) XOMA Corporation (NASDAQ:XOMA) ("XOMA" or the "Company") today announced it has commenced an underwritten registered public offering of shares of its Series A